SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
---|---|---|---|---|---|---|---|---|---|
20-Sep-24 7:26 PM View: | Rosett Max Chief Financial Officer | Immunome Inc. (IMNM) | 19-Sep-24 | Option Sale | 14,380 | $16.01 | $230,224.00 | (23%) 61.86K to 47.48K | |
20-Sep-24 7:26 PM View: | Rosett Max Chief Financial Officer | Immunome Inc. (IMNM) | 19-Sep-24 | Option Exercise | 42,000 | $1.05 | $44,100.00 | 212% 19.86K to 61.86K | |
21-May-24 4:13 PM View: | Siegall Clay B President and CEO Director | Immunome Inc. (IMNM) | 21-May-24 | Purchase | 20,434 | $13.78 | $281,548.00 | 5% 399.2K to 419.64K | |
22-May-24 4:49 PM View: | Bienaime Jean Jacques Director | Immunome Inc. (IMNM) | 21-May-24 | Purchase | 2,000 | $13.57 | $27,139.80 | 26% 7.62K to 9.62K | |
21-May-24 4:13 PM View: | Siegall Clay B President and CEO Director | Immunome Inc. (IMNM) | 20-May-24 | Purchase | 79,566 | $13.91 | $1,106,520.00 | 25% 319.64K to 399.2K | |
04-Oct-23 5:32 PM View: | Turner Bruce Chief Strategy Officer | Immunome Inc. (IMNM) | 02-Oct-23 | Private Purchase | 42,300 | $5.91 | $249,993.00 | 100% 0 to 42.3K | |
04-Oct-23 5:28 PM View: | Prendergast Franklyn G Director | Immunome Inc. (IMNM) | 02-Oct-23 | Grant | 60,840 | -- | -- | 100% 0 to 60.84K | |
04-Oct-23 5:35 PM View: | Siegall Clay B President and CEO Director | Immunome Inc. (IMNM) | 02-Oct-23 | Private Purchase | 169,204 | $5.91 | $999,996.00 | 112% 150.43K to 319.64K | |
03-Oct-23 10:00 PM View: | Rapp Michael Director | Immunome Inc. (IMNM) | 02-Oct-23 | Grant | 253,806 | $5.91 | $1,499,990.00 | 25% 1.03M to 1.28M | |
17-Jan-23 6:26 AM View: | Rapp Michael Director | Immunome Inc. (IMNM) | 15-Jan-23 | Grant | 17,500 | $4.00 | $70,000.00 | 2% 1.01M to 1.03M | |
17-Jan-23 6:30 AM View: | Wagenheim Philip Director | Immunome Inc. (IMNM) | 15-Jan-23 | Grant | 8,750 | $4.00 | $35,000.00 | 2% 397.4K to 406.15K | |
17-Jan-23 6:28 AM View: | Lefenfeld Michael Director | Immunome Inc. (IMNM) | 15-Jan-23 | Grant | 13,875 | $4.00 | $55,500.00 | 52% 26.87K to 40.75K | |
17-Jan-23 6:29 AM View: | Lamattina John L Director | Immunome Inc. (IMNM) | 15-Jan-23 | Grant | 15,125 | $4.00 | $60,500.00 | 29% 51.83K to 66.95K | |
14-Sep-21 7:28 AM View: | Rapp Michael Director | Immunome Inc. (IMNM) | 13-Sep-21 | Market Purchase | 25,962 | $19.96 | $518,202.00 | 3% 982.65K to 1.01M | 4% |
13-Sep-21 7:52 AM View: | Rapp Michael Director | Immunome Inc. (IMNM) | 10-Sep-21 | Market Purchase | 15,500 | $17.85 | $276,675.00 | 2% 967.15K to 982.65K | 4% |
13-Sep-21 7:52 AM View: | Rapp Michael Director | Immunome Inc. (IMNM) | 09-Sep-21 | Market Purchase | 30,450 | $18.19 | $553,774.00 | 3% 936.7K to 967.15K | 3% |
20-Aug-21 6:25 PM View: | Baron Richard A Director | Immunome Inc. (IMNM) | 18-Aug-21 | Option Exercise | 2,343 | $11.38 | $26,663.30 | 100% 0 to 2.34K | |
26-May-21 9:32 PM View: | Lefenfeld Michael Director | Immunome Inc. (IMNM) | 26-May-21 | Market Purchase | 1,335 | $19.03 | $25,405.10 | 5% 25.54K to 26.87K | (3%) |
26-May-21 9:31 PM View: | Rapp Michael Director | Immunome Inc. (IMNM) | 26-May-21 | Market Purchase | 2,300 | $18.94 | $43,562.00 | < 1% 934.4K to 936.7K | (2%) |
26-May-21 9:31 PM View: | Rapp Michael Director | Immunome Inc. (IMNM) | 25-May-21 | Market Purchase | 19,303 | $18.32 | $353,631.00 | 2% 915.09K to 934.4K | < 1% |
26-May-21 9:32 PM View: | Lefenfeld Michael Director | Immunome Inc. (IMNM) | 25-May-21 | Market Purchase | 2,715 | $18.44 | $50,064.60 | 12% 22.82K to 25.54K | < 1% |
26-May-21 9:28 PM View: | Sarma Purnanand D President and CEO Director | Immunome Inc. (IMNM) | 25-May-21 | Market Purchase | 10,500 | $18.41 | $193,305.00 | 100% 0 to 10.5K | < 1% |
26-May-21 9:31 PM View: | Rapp Michael Director | Immunome Inc. (IMNM) | 24-May-21 | Market Purchase | 31,895 | $18.38 | $586,230.00 | 4% 883.2K to 915.09K | < 1% |
26-May-21 9:26 PM View: | Lamattina John L Director | Immunome Inc. (IMNM) | 24-May-21 | Market Purchase | 5,440 | $18.57 | $101,028.00 | 12% 46.39K to 51.83K | (< 1%) |
26-May-21 9:32 PM View: | Lefenfeld Michael Director | Immunome Inc. (IMNM) | 24-May-21 | Market Purchase | 600 | $17.80 | $10,680.00 | 3% 22.22K to 22.82K | 4% |
26-May-21 9:29 PM View: | Wagenheim Philip Director | Immunome Inc. (IMNM) | 24-May-21 | Market Purchase | 13,500 | $18.35 | $247,725.00 | 4% 383.9K to 397.4K | < 1% |
08-Oct-20 6:11 PM View: | Lamattina John L Director | Immunome Inc. (IMNM) | 06-Oct-20 | Conversion | 46,388 | -- | -- | 100% 0 to 46.39K | |
08-Oct-20 6:14 PM View: | Morris I Wistar III 10% Owner | Immunome Inc. (IMNM) | 06-Oct-20 | Conversion | 38,464 | -- | -- | 4% 882.48K to 920.94K | |
08-Oct-20 6:16 PM View: | Rapp Michael Director | Immunome Inc. (IMNM) | 06-Oct-20 | Purchase | 83,332 | $12.00 | $999,984.00 | 6% 1.38M to 1.47M | |
08-Oct-20 6:12 PM View: | Lefenfeld Michael Director | Immunome Inc. (IMNM) | 06-Oct-20 | Conversion | 22,222 | -- | -- | 100% 0 to 22.22K | |
08-Oct-20 6:16 PM View: | Rapp Michael Director | Immunome Inc. (IMNM) | 06-Oct-20 | Conversion | 555,554 | -- | -- | 67% 827.64K to 1.38M | |
08-Oct-20 6:14 PM View: | Morris I Wistar III 10% Owner | Immunome Inc. (IMNM) | 06-Oct-20 | Conversion | 882,475 | -- | -- | 100% 0 to 882.48K | |
08-Oct-20 6:17 PM View: | Widlitz Michael Director | Immunome Inc. (IMNM) | 06-Oct-20 | Conversion | 51,315 | -- | -- | 100% 0 to 51.31K |